MA (EU) number
(Invented) name
Strength
Pharmaceutical 
form
Route of 
administration
Immediate
Packaging
Content 
(concentration)
Pack size
EU/1/21/1529/002
Vaxzevria
--1
Suspension for 
injection
Intramuscular 
use
Vial
(glass)
5 ml (10 doses 
of 0.5 ml)
10 multidose vials
(100 doses)
1One dose (0.5 mL) contains: 
Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)*, not less than 2.5 Ã— 108 infectious units (Inf.U)
* Produced in genetically modified human embryonic kidney (HEK) 293 cells and by recombinant DNA technology.
1/1
